Literature DB >> 8652366

Bisphosphonates in multiple myeloma: current status; future perspectives.

E Jantunen1, M Laakso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8652366     DOI： 10.1046/j.1365-2141.1996.d01-1689.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

Review 1.  Current drug therapy for multiple myeloma.

Authors:  Y W Huang; A Hamilton; O J Arnuk; P Chaftari; R Chemaly
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

2.  Percutaneous vertebroplasty for multiple myeloma of the cervical spine.

Authors:  Francisco Mont'Alverne; Jean-Noel Vallée; Remy Guillevin; Evelyne Cormier; Betty Jean; Michelle Rose; José Guilherme Caldas; Jacques Chiras
Journal:  Neuroradiology       Date:  2009-01-06       Impact factor: 2.804

3.  Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.

Authors:  Shicong Zhu; Zhihua Wang; Zijian Li; Hongling Peng; Yunya Luo; Mingyang Deng; Ruijuan Li; Chongwen Dai; Yunxiao Xu; Sufang Liu; Guangsen Zhang
Journal:  Oncotarget       Date:  2015-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.